US Patent No: 6,057,373
Number of patents in Portfolio can not be more than 2000
Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
Stats
-
May 2, 2000
Issued date -
Jan 4, 1999
filing date -
09/224,829
serial no -
In Force
status
Importance
Loading Importance Indicators...
Abstract
The present invention describes a novel treatment for movement disorders, including tardive dyskinesia and tardive dystonia, and focal dystonias not due to neuroleptics, including blepharospasm, Meige syndrome, and occupational dystonias. The treatment of the present invention utilizes agents that act as NMDA-type glutamate receptor antagonists The invention also involves the use of an ion channel blocking agent to augment the therapeutic action of the drug treatments described. A particularly preferred ion channel blocking agent is magnesium.
Loading the Abstract Image...
First Claim
Related Publications
Loading Related Publications...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 5,455,279 Regimen method of mediating neuronal damage using nitroglycerine | 13 | 1993 | |
| 5,747,545 Method of preventing NMDA receptor complex-mediated Neuronal damage | 8 | 1995 | |
| 5,614,560 Method of preventing NMDA receptor-mediated neuronal damage | 25 | 1995 | |
|
|
|||
| 5,061,703 Adamantane derivatives in the prevention and treatment of cerebral ischemia | 34 | 1990 | |
| 5,382,601 Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof | 24 | 1993 | |
|
|
|||
| 5,206,248 Method for reducing emotional lability | 14 | 1992 | |
|
|
|||
| 4,355,043 Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane | 21 | 1980 | |
|
|
|||
| 5,262,162 Cerebral-activating extract | 11 | 1991 | |
|
|
|||
| 5,670,477 Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents | 53 | 1995 | |
|
|
|||
| 5,602,150 Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia | 12 | 1995 | |
|
|
|||
| 4,233,229 Preparation of salt-free N-acyl taurines | 9 | 1978 | |
|
|
|||
| 5,604,198 Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents | 40 | 1994 | |